
Synvisc One for intra-articular injection 1 syringe 6ml
Indications: Synvisc-One (a viscosupplement) is a simple intra-articular injection used to relieve pain and discomfort associated with osteoarthritis of the knee for up to six months.
IMPORTANT! New orders to the United States are temporarily suspended.
Sinovial® is indicated in cases of pain or reduced mobility in order to restore the physiological and rheological properties of arthritic joints.
COMPOSITION
Highly purified 0.8% sodium hyaluronate (8 mg hyaluronic acid/1 ml physiological buffered sodium chloride solution), sodium chloride, sodium phosphate and water for injection (qsp 100%).
Sinovial is a buffered physiological hyaluronic acid solution with viscoelastic properties. Sinovial contains hyaluronic acid with a molecular weight between 800 and 1200 kDalton.
Sodium hyaluronate consists of repeating disaccharide units of N-acetylglucosamine and sodium glucuronate. It is an essential component of the synovial fluid and gives it its visco-elastic properties.
Sinovial 2 ml is indicated in case of pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or alterations of joints and tendons. The improvement is instantaneous: the global WOMAC index decreases after the first injection and, from the third injection onwards, the reduction becomes statistically significant.
Sinovial Mini is suitable for viscosupplementation of small joints: all wrist and hand joints, including interphalangeal, intercarpal, metacarpophalangeal, carpometacarpal, distal radio-ulnar and radiocarpal joints, all foot joints and the temporomandibular joint, and tendon sheaths (e.g. in cases of flexor tendon tenosynovitis or finger impingement)
Sinovial is a suitable joint fluid replacement agent. It restores the physiological and rheological conditions of the arthritic joint. The therapeutic effect is based on the special properties of its hyaluronic acid. The hyaluronic acid in Sinovial is obtained by fermentation and is chemically unmodified.
Sinovial acts only in the joints in which it has been injected; it has no systemic effect.
It is recommended that Sinovial 2 ml be administered in a regimen of 3-5 injections given at one-week intervals, leading to a reduction in pain and swelling, as well as improvement in function, which may last up to 24 weeks.
It is recommended that Sinovial Mini be administered in a regimen of 2-3 treatments per year, with intervals of 4-6 months, as determined by the physician.
Aspirate any joint effusion before injecting Sinovial. Do not use Sinovial if the package is open or damaged. Inject Sinovial at room temperature and observe strict aseptic precautions. Be especially careful not to touch the syringe opening when removing the cap. Use the needle provided (Sinovial 2 ml) or an appropriate size needle from 18 to 22G (Sinovial Mini). To ensure a tight connection and prevent leakage during administration, fit the needle securely to the syringe connector.
Do not inject Sinovial into an infected or severely inflamed joint, or in patients with a skin condition or infection at the injection site.
Intra-articular injection should only be performed by a physician.
Do not use disinfectants containing quaternary ammonium salts or chlorhexidine to prepare the skin, as precipitation of hyaluronic acid is possible in their presence.
The possible presence of an air bubble does not compromise the characteristics of the product.
The injection site must be located on healthy skin. Inject only into the joint space. Do not inject intravascularly or outside the tendon sheath. Do not inject outside the joint space, into the synovial tissue or the joint capsule. Extra-articular infiltration of Sinovial, or outside the tendon sheath, may cause local adverse effects. Do not use Sinovial in the presence of significant intra-articular effusion.
Do not resterilize. Syringe and needles are for single use only. Do not reuse to avoid contamination.
The contents of the pre-filled syringe are sterile. The syringe and needle are supplied in a sealed blister pack. The outer surface of the syringe is not sterile.
As with any invasive joint procedure, it is recommended that the patient refrain from physical exertion after the joint injection and only resume normal activities after a few days.
Associated manifestations such as pain, warmth, redness or swelling may occur at the injection site after the use of Sinovial.
Ice applied to the treated joint may relieve such associated events. These usually subside within a short time.
The patient should inform the physician of any adverse effects that may occur later.
No interactions with other drugs have been reported to date.
Do not use after the date shown on the package.
Store at a temperature between 0°C and 25°C, away from sources of heat.
Do not freeze.
Sinovial should be used immediately after opening and discarded after use.
Indications: Synvisc-One (a viscosupplement) is a simple intra-articular injection used to relieve pain and discomfort associated with osteoarthritis of the knee for up to six months.
Indicated for the symptomatic treatment of osteoarthritis, particularly of the hip and knee. Chondrosulf contains chondroitin sulfate and is indicated for adults (over 15).
Chondrosulf is available in several dosages:
Chondrolsulf 400 mg box 84 capsules
Chondrolsulf 800 mg box 30 capsules
This medicine is used as a ground modifier especially during infectious and viral conditions, flu-like conditions, inflammatory rheumatic conditions and during arthrosis.
Description : This medication is recommended for painful osteoarthritis of the knee, with effusion.
Flect'Expert Patch Harpagophytum unties, softens and relieves immediately the joint and muscle tensions of everyday life by providing a warm effect.
Indications: STRUCTUM is used in adults (over 15 years of age) for the treatment of pain and functional discomfort in osteoarthritis of the knee and hip. This drug has a slow onset of action, delayed by about 2 months, and its effect may persist after treatment has been stopped.
Indications: This product is indicated in adults (over 15 years of age) for the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and contusions. This drug is indicated in adults for the treatment of painful flare-ups of osteoarthritis of the knee, following initial medical advice.
Indicated in the symptomatic treatment of osteoarthritis.
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Sinovial® HL is indicated for pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy linked to joint alterations.
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Arthrum HCS 40mg/2ml is indicated for all types of painful synovial joint arthritis, particularly gonarthrosis.
Arthrum HCS is biologically similar to human synovial fluid and participates in the following functions: Protect the cartilage, Protect the synovial membrane, Reduce pain and improve mobility
A cream to soothe and limit joint pain Designed to relieve lower back pain, this warming cream has anti-inflammatory and moisturizing properties. It provides a sensation of warmth that helps relax muscles and joints. Mobility improves day by day with regular application.
Indications: This drug is indicated in adults (over 15 years), in the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and bruises. This drug is indicated in adults in the treatment of painful flare-ups of osteoarthritis of the knee, after a first medical opinion.
Flector effigel is a medicine containing an anti-inflammatory and an analgesic, it is used in the short term local treatment, in adults and children over 15 years old, in case of benign trauma: sprain, strain, or contusion.